Companion Animal Diagnostics Market

The report "Companion Animal Diagnostic Market by Product (Consumable, Instrument), Technology (Immunodiagnostic, ELISA, PCR Test, Urinalysis, Hematology), Animal Type (Dog, Cat), Application (Clinical Pathology, Virology), End User - Global Forecast to 2031" is projected to grow from USD 3.56 billion in 2026 and to reach USD 5.40 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period.

Browse 400 market data Tables and 65 Figures spread through 450 Pages and in-depth TOC on "Companion Animal Diagnostic Market by Product (Consumable, Instrument), Technology (Immunodiagnostic, ELISA, PCR Test, Urinalysis, Hematology), Animal Type (Dog, Cat), Application (Clinical Pathology, Virology), End User - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/companion-animal-diagnostic-market-173823870.html

The market for companion animal diagnostics is experiencing significant growth driven by rising pet ownership, increased veterinary healthcare spending, and rapid technological advances. Since people want diagnostic solutions that are fast, accurate, and cheap, vet practices and labs are getting advanced instruments, in-clinic molecular tests, and digital platforms. Changes such as AI-powered image analysis, automated analyzers, liquid biopsy, and cloud-connected diagnostic ecosystems are opening up clinical workflows and enabling faster, more accurate disease detection in pets. On the other hand, improved assay chemistry, quality tools, and integrated data systems are leading to more reliable results, greater traceability, and compliance with regulatory requirements. Veterinary experts are now paying closer attention to prevention, chronic disease monitoring, and personalized treatment, which is driving the market's continued growth. The collaboration among diagnostic firms, reference labs, and tech providers is also increasing, enabling them to offer scalable, data-driven diagnostic solutions.

By application, clinical pathology segment accounted for largest market share in 2025.

In the companion animal diagnostics market, the clinical pathology segment accounted for the largest market share in 2025. This dominance stems from its foundation for most general veterinary evaluations, such as hematology, biochemistry, urinalysis, cytology, and electrolyte analyses. These analyses are deemed crucial for diagnosing a wide range of common conditions, including infections, metabolic disorders, organ dysfunction, and chronic diseases. In addition, the ubiquitous presence of in-house analyzers, short turnaround times, and high sensitivity have further fueled their popularity in veterinary practices. Furthermore, the increasing incidence of age-related conditions, preventive medicine screening, and chronic disease surveillance in dogs and cats has been continuously fueling high testing volumes, thereby solidifying the central importance of clinical pathology as the most popular and indispensable diagnostic modality.

By end user, homecare settings segment to record highest CAGR during forecast period.

The homecare settings segment is expected to record the highest CAGR during the forecast period because it relies heavily on outsourcing to access advanced technologies, specialized expertise, and GMP-compliant facilities that it lacks in-house. Their focus on innovative platforms, such as novel biologics, gene-based therapies, advanced formulations, and digital health tools, drives high demand for CDMO and CRO support across early-stage R&D, scale-up, and clinical studies. With strong investor interest and a surge in new pet health and livestock innovation ventures, these companies are rapidly increasing their outsourcing needs, fueling segment growth.

By region, North America accounted for largest market share in 2025.

In 2025, North America accounted for the largest share of the companion animal diagnostics market. Because of the high pet ownership rate, well-developed veterinary healthcare infrastructure, and significant investment in advanced diagnostic technologies, North America dominated the companion animal diagnostics market. There is a wide availability of specialized veterinary services in the region, along with high adoption of in-house diagnostic tools and AI-driven platforms that improve testing accuracy and efficiency. Furthermore, pet insurance, increased awareness of preventive care, and the presence of leading diagnostic companies are major factors driving demand for veterinary diagnostics in North America. This solidifies the region's position as a dominant market leader.

Key Market Players

The prominent players in the companion animal diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis Services LLC (US), Mars, Incorporated (US), bioMérieux (France), FUJIFILM Corporation (Japan), Thermo Fisher Scientific Inc. (US), Neogen Corporation (US), Virbac (France), INDICAL BIOSCIENCE GmbH (Germany), and Innovative Diagnostics (France), among others.

Don’t miss out on business opportunities in Companion Animal Diagnostics Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/